Leerink Partners Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $24

Moomoo News03:31 ET · Ratings

Hims & Hers Health: Balancing Strong Performance With Regulatory Uncertainty – Hold Rating Maintained

TipRanks03:16 ET · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Hims & Hers Health (HIMS) and MannKind (MNKD)

TipRanks03:10 ET · Ratings

Hims & Hers Health Options Spot-On: On November 5th, 162.7K Contracts Were Traded, With 342.86K Open Interest

Moomoo News16:30 ET

Hims & Hers Stock Rises on Earnings and Planned Generic Version of Novo Nordisk Diabetes Drug -- Barrons.com

Barron's11:38 ET

What's Going On With Hims & Hers Health Stock Tuesday?

Benzinga11:01 ET